Loading…
avatar for Doug Stover

Doug Stover

AstraZeneca
Head of Innovation, Alexion Rare Disease Business Unit,
Douglas Stover is the Global Head of Innovation at Alexion.  His team is responsible for building the capabilities and culture to accelerate ideation, incubation and scaling of ideas that will enhance core competencies as well as explore disruptive concepts.

Douglas joined Alexion in 2020 after spending four years at UCB where he led the Global Patient Experience and Technology Practice. At UCB, his team partnered with business units across geographies and therapy areas to define patient experience goals and build the capabilities to ensure sustainable success. Prior to joining UCB, Douglas spent 10 years with Gallup, a research-based consultancy, where he served as a strategic advisor to clients building customer focused organizations. Previous experience includes senior positions at The Advisory Board and OgilvyOne.

Douglas received his Bachelor of Science from the Pennsylvania State University and Master of Business Administration from Georgetown University.